Skip to main content
Elsevier
View Cart

Hepatobiliary & Pancreatic Diseases International

  • Annual issues: 1 volume, 6 issues

  • ISSN: 1499-3872

Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R), owned by the First Affiliated Hospital, Zhejiang University School of Medicine… Read more

Subscription options

Subscription options

Sorry, this title is not available for purchase in your country/region.

SHIPPING UPDATE

Journal orders are currently subject to delays

While we upgrade our fulfilment system. We endeavour to ship Journal orders as soon as possible.

Institutional subscription on ScienceDirect

Request a sales quote

Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R), owned by the First Affiliated Hospital, Zhejiang University School of Medicine in China, publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases.

Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and histological aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Reports, Clinical Summary, New Techniques, and Clinical Images. The journal also deals with the basic sciences and experimental work. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper. Manuscripts, letters, and other communications should be submitted via https://mc03.manuscriptcentral.com/hbpdint.

Benefits to authors

We also provide many author benefits such as free PDFs.

If you require further information or help, please contact: Hepatobiliary & Pancreatic Diseases International, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China. Tel: +86-571- 87236559, +86-571-87236600; Fax: +86-571-87236559; Email: [email protected], [email protected].